Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis.
Journal: Digestive diseases (Basel, Switzerland)
Published: May 18, 2021
Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments.
Journal: Journal of clinical gastroenterology
Published: August 03, 2020
Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative Colitis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: July 07, 2020
Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice. Authors' reply.
Journal: Alimentary pharmacology & therapeutics
Published: May 20, 2020
Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: April 24, 2020
Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management.
Journal: Inflammatory bowel diseases
Published: April 07, 2020
Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical Program.
Journal: Inflammatory bowel diseases
Published: March 11, 2020
Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme.
Journal: Alimentary pharmacology & therapeutics
Published: July 04, 2019
Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States.
Journal: Inflammatory bowel diseases
Published: May 13, 2019
An economic evaluation of tofacitinib for the treatment of moderately-to-severely active ulcerative colitis: modeling the cost of treatment strategies in the United States.
Journal: Journal of medical economics
Published: April 24, 2019
The Impact of Raising the Bar for Clinical Trials in Ulcerative Colitis.
Journal: Journal of Crohn's & colitis
Published: March 18, 2019
Last Updated: 09/26/2026